Director Shareholding

GlaxoSmithKline PLC
2 July 2002

                              Directors' Interests


I give below details of changes in the directors' interests in the Ordinary
Shares and American Depository Shares (ADSs) of GlaxoSmithKline plc.


On 30 June 2002, the following non-executive Directors were provisionally
allocated the following awards over Ordinary Shares and ADSs in the Company
under the automatic share allocation arrangements for non-executive Directors
for the period of service from 1 April to the 30 June 2002, as listed below.


Non Executive Director                Ordinary Shares         American Depository
                                                                 Shares (ADS)
Sir Roger Hurn                              750
Paul Allaire                                                          125
Dr Michele Barzach                          250
Sir Christopher Hogg                        250
Sir Peter Job                               250
John McArthur                                                         125
Donald McHenry                                                        125
Sir Ian Prosser                             250
Dr Ronaldo Schmitz                          250
Dr Lucy Shapiro                                                       125




At the same time the following non-executive Directors were provisionally
allocated the following awards over Ordinary Shares in the Company under the
share election element of the share allocation arrangements for non-executive
Directors for the period of service from 1 April to the 30 June 2002, as listed
below.






Non Executive Director                Ordinary Shares
Sir Roger Hurn                             719.94
Sir Peter Job                              809.94
Sir Ian Prosser                            404.97
Dr Ronaldo Schmitz                         395.97


The Company and the Directors were informed of these allocations on 1 July 2002.


S M Bicknell

Company Secretary

2 July 2002






                      This information is provided by RNS
            The company news service from the London Stock Exchange